| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -779,7 € | -100.6% | -388,8 € | — | ||
| EBITDA | -1,1 k € | -185.2% | -388,8 € | — | ||
| Operating profit | -1,1 k € | -185.2% | -388,8 € | — | ||
| Profit/loss | -1,2 k € | -207.6% | -388,8 € | — | ||
| Equity | 23,4 k € | -4.9% | 24,6 k € | -1.6% | 25,0 k € | |
| Total assets | 555,7 k € | +21.8% | 456,3 k € | +47.2% | 310,0 k € | |
| Cash | 1,8 k € | -23.2% | 2,4 k € | -90.5% | 25,0 k € | |
| Debts | 532,3 k € | +23.3% | 431,7 k € | +51.5% | 285,0 k € | |
Private limited company · Antwerpen · incorporated on 05/11/2020
Private limited company loss-making in the latest fiscal year. Cash position declining (-23.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Medicorps-Invest is a Private limited company incorporated in 2020. Its registered office is in Antwerpen.